Something I know nothing about. Apparently a lab at Berkley has designed a DNA-protein chimera which will specifically bind cancer markers in levels too low for traditional tests. Then they use existing DNA technology (PCR) to amplify the DNA and determine how much of the blood marker is present. It's more sensitive, but PCR isn't exactly quantitative, because it's a logarithmic process. Anyway, sounds cool.